An Indian pharmacology study finds a water-based guava extract tackled three linked problems of diabetes at once in animals, though human evidence is still lacking.

Diabetes is rarely a single problem. High blood sugar tends to arrive with company: abnormal levels of cholesterol and other fats in the blood, and a steady accumulation of cellular damage from oxidative stress. Together, those companions drive many of the disease’s most serious complications, including heart disease. Any treatment that could address all three at once would be of considerable interest.

A new study published in the journal Glucolipid Metabolic Disorders suggests that a familiar tropical plant may be worth a closer look. Researchers led by Raj Kumari, professor and dean at I.T.S College of Pharmacy in Muradnagar, Ghaziabad, in the Indian state of Uttar Pradesh, found that a water-based extract of guava improved blood sugar, blood lipids and antioxidant defenses in diabetic rats.

The results are preliminary and confined to animals. But they add to a long list of reasons researchers have been interested in a plant that traditional healers have used for generations.

A traditional remedy under the microscope

Guava, known scientifically as Psidium guajava, grows throughout the tropics and subtropics and is prized for its fragrant fruit. Its leaves, bark and fruit have also been used in traditional medicine across those regions for a wide range of ailments, and earlier laboratory studies have explored various parts of the plant for potential health effects.

Kumari’s team wanted to know whether guava’s benefits might extend beyond blood sugar control. Rather than asking only whether the plant could lower glucose, they set out to see whether it could also correct the lipid imbalances and oxidative damage that so often accompany diabetes.

To do that, they prepared an aqueous, or water-based, guava extract, which they called PsAq, and tested it in a widely used animal model of the disease.

How the experiment worked

The researchers induced diabetes in albino Wistar rats with a single injection of streptozotocin, a compound that damages the insulin-producing cells of the pancreas and produces a diabetes-like condition. It is a standard tool in laboratory diabetes research.

The diabetic rats then received oral doses of the guava extract every day for 21 days, at either 150 milligrams or 250 milligrams per kilogram of body weight. At the end of the treatment period, the team measured a broad panel of biochemical markers.

Those included fasting blood glucose; several measures of blood fats, including total cholesterol, triglycerides, low-density lipoprotein (LDL), very-low-density lipoprotein (VLDL) and high-density lipoprotein (HDL); a calculated atherogenic index reflecting cardiovascular risk; and multiple markers of oxidative stress and antioxidant activity in tissue, including in the pancreas.

Improvements on three fronts

The extract significantly lowered fasting blood glucose in the diabetic animals. That alone would be notable, but the lipid results were arguably more interesting.

Treated rats showed reductions in total cholesterol and triglycerides, as well as in LDL and VLDL, the fractions often described as “bad” cholesterol because of their association with arterial plaque. At the same time, levels of HDL, the cholesterol type generally considered protective for the heart, went up. The researchers characterized this combination as both antihyperlipidemic, meaning it lowered excess blood fats, and antiatherogenic, meaning it pushed against the processes that lead to clogged arteries.

The extract also appeared to shore up the body’s defenses against oxidative damage. It reduced lipid peroxidation, a marker of oxidative injury to fats within tissues, and increased levels of glutathione, one of the body’s most important natural antioxidants. The activity of several antioxidant enzymes improved as well.

Why the combination matters

Taken together, the findings suggest the guava extract works through more than one route: helping to control blood sugar, correcting some of the lipid abnormalities associated with diabetes, and strengthening antioxidant defenses against the free-radical damage that chronically high blood sugar tends to cause.

The authors emphasize that this multi-pronged effect is especially relevant because oxidative stress and abnormal blood lipids are so tightly bound up with the long-term complications of diabetes. Persistently high glucose generates reactive molecules that damage cells and blood vessels, and abnormal lipid profiles accelerate the development of cardiovascular disease, the leading cause of death among people with diabetes. A single agent that nudges all of these factors in a healthier direction would be an attractive candidate for further development.

Guava is also rich in plant compounds, such as polyphenols and flavonoids, that are known for antioxidant activity, which offers a plausible biological basis for the effects observed. The present study, however, did not isolate which specific compounds were responsible.

Important limits

The research comes with substantial caveats, which the authors themselves acknowledge. This was an animal study, and results in rats frequently fail to translate to people. The streptozotocin model mimics some features of diabetes, particularly the loss of insulin-producing cells, but it does not capture the full complexity of the human disease, especially the insulin resistance that characterizes type 2 diabetes.

The treatment period was also short, just three weeks, and the study does not establish what dose might be appropriate or safe in humans, or how guava extract might interact with existing diabetes medications.

The authors present their results as evidence supporting guava’s potential as a natural therapeutic option for diabetes and its frequent companions, high blood lipids and oxidative stress. But they are clear that the findings should be seen as a reason for further investigation, not as proof of an established treatment.

For now, the practical takeaway is modest. People with diabetes should not swap prescribed medications for guava tea or supplements on the strength of rodent data. What the study does provide is a well-defined set of effects worth testing more rigorously, first in further laboratory work to pin down the active compounds and mechanisms, and eventually, if the evidence holds, in carefully designed human trials.

Featured image: Photo by Jane T D. on Pexels.com

---

Endnotes

1. Kumari, R. (corresponding author). “Therapeutic Effects of Psidium guajava on Lipids and Pancreatic Antioxidants in Streptozotocin-induced Diabetic Rats.” Glucolipid Metabolic Disorders (2026, in press, available online). DOI: 10.2174/0129499011433204260702182239.
2. Bentham Science Publishers. “Guava leaf extract shows promise against diabetes-related lipid problems and oxidative stress: a study in rats.” News release via EurekAlert!, July 28, 2026. https://www.eurekalert.org/news-releases/1137847